Basal cell and squamous cell skin cancers explained

A pathology report should provide the exact tumour name. That wording matters because the expected behaviour, margin planning and follow-up can differ. If the phrase came from a conversation rather than a report, ask the clinician to clarify which diagnosis was intended.

Basal cell carcinoma begins in basal cells of the outer skin layer and often damages tissue mainly where it grows. Squamous cell carcinoma begins in squamous cells and may require closer assessment of features linked with spread, such as tumour depth, nerve involvement, location and immune status.

Neither can be identified reliably from a photograph or texture alone. A biopsy lets a pathologist examine the cells, identify the cancer type and describe features that guide treatment. Melanoma is another separate skin cancer arising from pigment-producing cells.

Request a copy of the pathology report and note the exact diagnosis, body site, subtype and margin wording. The treating clinician may recommend complete surgical removal, a margin-controlled procedure or another approach after considering the report and your general health.

Protect exposed skin from ultraviolet light and examine your skin in good lighting. Record a clear photograph of a concerning area for comparison without delaying an appointment. Follow-up should cover both the treated site and the rest of the skin.

Book a dermatology assessment for a sore that does not heal, repeated bleeding or crusting, a growing lump, a persistent scaly patch or a changing pigmented mark. Basal cell carcinoma and squamous cell carcinoma can present with some of these features, but an examination and sometimes biopsy are needed to determine the cause.

Seek prompt care if a lesion is growing quickly, causes new numbness or weakness, becomes markedly painful, or is accompanied by a new lump near the affected region. Urgency comes from the change itself and its clinical context, not from guessing a diagnosis.

Ask whether the report names basal cell carcinoma, squamous cell carcinoma or another tumour; whether the sample represents a biopsy or complete removal; and whether further treatment is advised. Also ask what changes at the scar or elsewhere should trigger an earlier review.